Stay updated on SAGE-217 for MDD Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.

Latest updates to the SAGE-217 for MDD Relapse Prevention Clinical Trial page
- Check7 days agoChange DetectedThe history page now includes a glossary option and updated explanations for color-coded changes (green for additions and red for deletions) with a new Revision: v3.4.0. The No FEAR Act data label was adjusted and the previous Revision: v3.3.4 entry was removed.SummaryDifference1.0%

- Check14 days agoNo Change Detected
- Check42 days agoChange DetectedAdded a new Revision: v3.3.3 entry to the study history and removed the HHS Vulnerability Disclosure and Revision: v3.3.2 from the page.SummaryDifference0.2%

- Check64 days agoChange DetectedThe page history shows a new revision entry (v3.3.2) and the removal of an earlier revision (v3.3.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedThe history page shows a new site revision label (v3.3.1) replacing v3.2.0, with no changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedRemoved the government funding operating status notice from the page. It previously warned that information may not be up to date and directed users to opm.gov for status updates.SummaryDifference0.7%

- Check92 days agoChange DetectedThe latest version updates Study Identification, Study Status, Sponsor/Collaborators, and Study Description, reflecting changes in recruitment status and study details.SummaryDifference0.1%

Stay in the know with updates to SAGE-217 for MDD Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 for MDD Relapse Prevention Clinical Trial page.